Cotrimoxazole Prophylaxis Compliance Among HIV Exposed Infants
8 Angebote vergleichen
Bester Preis: € 30,36 (vom 25.10.2019)1
Cotrimoxazole Prophylaxis Compliance Among HIV Exposed Infants
DE HC NW
ISBN: 9783659893674 bzw. 3659893676, in Deutsch, LAP Lambert Academic Publishing, gebundenes Buch, neu.
Lieferung aus: Deutschland, Versandkostenfrei innerhalb von Deutschland.
Cotrimoxazole prophylaxis is a well tolerated and cost-effective intervention for people living with HIV. It should be implemented as an integral component of the HIV chronic care package and a key element of pre-antiretroviral therapy care. However, provision is extremely low with just 8% of infants born to pregnant women with HIV in 2008 initiating cotrimoxazole prophylaxis by two months of age (UNAIDS, 2010). Greater advocacy for the use of cotrimoxazole prophylaxis in children is urgently Cotrimoxazole prophylaxis is a well tolerated and cost-effective intervention for people living with HIV. It should be implemented as an integral component of the HIV chronic care package and a key element of pre-antiretroviral therapy care. However, provision is extremely low with just 8% of infants born to pregnant women with HIV in 2008 initiating cotrimoxazole prophylaxis by two months of age (UNAIDS, 2010). Greater advocacy for the use of cotrimoxazole prophylaxis in children is urgently required. Cotrimoxazole prophylaxis can reduce morbidity and mortality among HIV exposed infants if used consistently. The study focused on determining the factors associated with its compliance by HIV exposed infants in Chikankata District. The findings showed that 78% of mothers/caretakers did not comply with cotrimoxazole due to several factors: socio-cultural, misconceptions, lack of social support, non availability of the drug at health facility, negative attitude of health care providers and lack of nurses follow up of mothers/caretakers, long distances to health facilities, inadequate staffing levels. This underpins the importance of multi-sectoral response in addressing the pandemic. Lieferzeit 1-2 Werktage.
Cotrimoxazole prophylaxis is a well tolerated and cost-effective intervention for people living with HIV. It should be implemented as an integral component of the HIV chronic care package and a key element of pre-antiretroviral therapy care. However, provision is extremely low with just 8% of infants born to pregnant women with HIV in 2008 initiating cotrimoxazole prophylaxis by two months of age (UNAIDS, 2010). Greater advocacy for the use of cotrimoxazole prophylaxis in children is urgently Cotrimoxazole prophylaxis is a well tolerated and cost-effective intervention for people living with HIV. It should be implemented as an integral component of the HIV chronic care package and a key element of pre-antiretroviral therapy care. However, provision is extremely low with just 8% of infants born to pregnant women with HIV in 2008 initiating cotrimoxazole prophylaxis by two months of age (UNAIDS, 2010). Greater advocacy for the use of cotrimoxazole prophylaxis in children is urgently required. Cotrimoxazole prophylaxis can reduce morbidity and mortality among HIV exposed infants if used consistently. The study focused on determining the factors associated with its compliance by HIV exposed infants in Chikankata District. The findings showed that 78% of mothers/caretakers did not comply with cotrimoxazole due to several factors: socio-cultural, misconceptions, lack of social support, non availability of the drug at health facility, negative attitude of health care providers and lack of nurses follow up of mothers/caretakers, long distances to health facilities, inadequate staffing levels. This underpins the importance of multi-sectoral response in addressing the pandemic. Lieferzeit 1-2 Werktage.
2
Cotrimoxazole Prophylaxis Compliance Among HIV Exposed Infants
DE PB NW
ISBN: 9783659893674 bzw. 3659893676, in Deutsch, LAP Lambert Academic Publishing, Taschenbuch, neu.
Lieferung aus: Deutschland, Versandkosten nach: Deutschland, Versandkostenfrei.
Von Händler/Antiquariat, buecher.de GmbH & Co. KG, [1].
Cotrimoxazole prophylaxis is a well tolerated and cost-effective intervention for people living with HIV. It should be implemented as an integral component of the HIV chronic care package and a key element of pre-antiretroviral therapy care. However, provision is extremely low with just 8% of infants born to pregnant women with HIV in 2008 initiating cotrimoxazole prophylaxis by two months of age (UNAIDS, 2010). Greater advocacy for the use of cotrimoxazole prophylaxis in children is urgently required. Cotrimoxazole prophylaxis can reduce morbidity and mortality among HIV exposed infants if used consistently. The study focused on determining the factors associated with its compliance by HIV exposed infants in Chikankata District. The findings showed that 78% of mothers/caretakers did not comply with cotrimoxazole due to several factors: socio-cultural, misconceptions, lack of social support, non availability of the drug at health facility, negative attitude of health care providers and lack of nurses follow up of mothers/caretakers, long distances to health facilities, inadequate staffing levels. This underpins the importance of multi-sectoral response in addressing the pandemic. Versandfertig in 3-5 Tagen, Softcover, Neuware.
Von Händler/Antiquariat, buecher.de GmbH & Co. KG, [1].
Cotrimoxazole prophylaxis is a well tolerated and cost-effective intervention for people living with HIV. It should be implemented as an integral component of the HIV chronic care package and a key element of pre-antiretroviral therapy care. However, provision is extremely low with just 8% of infants born to pregnant women with HIV in 2008 initiating cotrimoxazole prophylaxis by two months of age (UNAIDS, 2010). Greater advocacy for the use of cotrimoxazole prophylaxis in children is urgently required. Cotrimoxazole prophylaxis can reduce morbidity and mortality among HIV exposed infants if used consistently. The study focused on determining the factors associated with its compliance by HIV exposed infants in Chikankata District. The findings showed that 78% of mothers/caretakers did not comply with cotrimoxazole due to several factors: socio-cultural, misconceptions, lack of social support, non availability of the drug at health facility, negative attitude of health care providers and lack of nurses follow up of mothers/caretakers, long distances to health facilities, inadequate staffing levels. This underpins the importance of multi-sectoral response in addressing the pandemic. Versandfertig in 3-5 Tagen, Softcover, Neuware.
3
Cotrimoxazole Prophylaxis Compliance Among HIV Exposed Infants (2010)
~EN NW AB
ISBN: 9783659893674 bzw. 3659893676, vermutlich in Englisch, neu, Hörbuch.
Lieferung aus: Deutschland, Lieferzeit: 5 Tage.
Cotrimoxazole prophylaxis is a well tolerated and cost-effective intervention for people living with HIV. It should be implemented as an integral component of the HIV chronic care package and a key element of pre-antiretroviral therapy care. However, provision is extremely low with just 8% of infants born to pregnant women with HIV in 2008 initiating cotrimoxazole prophylaxis by two months of age (UNAIDS, 2010). Greater advocacy for the use of cotrimoxazole prophylaxis in children is urgently required. Cotrimoxazole prophylaxis can reduce morbidity and mortality among HIV exposed infants if used consistently. The study focused on determining the factors associated with its compliance by HIV exposed infants in Chikankata District. The findings showed that 78% of mothers/caretakers did not comply with cotrimoxazole due to several factors: socio-cultural, misconceptions, lack of social support, non availability of the drug at health facility, negative attitude of health care providers and lack of nurses follow up of mothers/caretakers, long distances to health facilities, inadequate staffing levels. This underpins the importance of multi-sectoral response in addressing the pandemic.
Cotrimoxazole prophylaxis is a well tolerated and cost-effective intervention for people living with HIV. It should be implemented as an integral component of the HIV chronic care package and a key element of pre-antiretroviral therapy care. However, provision is extremely low with just 8% of infants born to pregnant women with HIV in 2008 initiating cotrimoxazole prophylaxis by two months of age (UNAIDS, 2010). Greater advocacy for the use of cotrimoxazole prophylaxis in children is urgently required. Cotrimoxazole prophylaxis can reduce morbidity and mortality among HIV exposed infants if used consistently. The study focused on determining the factors associated with its compliance by HIV exposed infants in Chikankata District. The findings showed that 78% of mothers/caretakers did not comply with cotrimoxazole due to several factors: socio-cultural, misconceptions, lack of social support, non availability of the drug at health facility, negative attitude of health care providers and lack of nurses follow up of mothers/caretakers, long distances to health facilities, inadequate staffing levels. This underpins the importance of multi-sectoral response in addressing the pandemic.
4
Cotrimoxazole Prophylaxis Compliance Among HIV Exposed Infants (2010)
~EN PB NW
ISBN: 9783659893674 bzw. 3659893676, vermutlich in Englisch, LAP Lambert Academic Publishing, Taschenbuch, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Cotrimoxazole Prophylaxis Compliance Among HIV Exposed Infants: Cotrimoxazole prophylaxis is a well tolerated and cost-effective intervention for people living with HIV. It should be implemented as an integral component of the HIV chronic care package and a key element of pre-antiretroviral therapy care. However, provision is extremely low with just 8% of infants born to pregnant women with HIV in 2008 initiating cotrimoxazole prophylaxis by two months of age (UNAIDS, 2010). Greater advocacy for the use of cotrimoxazole prophylaxis in children is urgently required. Cotrimoxazole prophylaxis can reduce morbidity and mortality among HIV exposed infants if used consistently. The study focused on determining the factors associated with its compliance by HIV exposed infants in Chikankata District. The findings showed that 78% of mothers/caretakers did not comply with cotrimoxazole due to several factors: socio-cultural, misconceptions, lack of social support, non availability of the drug at health facility, negative attitude of health care providers and lack of nurses follow up of mothers/caretakers, long distances to health facilities, inadequate staffing levels. This underpins the importance of multi-sectoral response in addressing the pandemic. Englisch, Taschenbuch.
Cotrimoxazole Prophylaxis Compliance Among HIV Exposed Infants: Cotrimoxazole prophylaxis is a well tolerated and cost-effective intervention for people living with HIV. It should be implemented as an integral component of the HIV chronic care package and a key element of pre-antiretroviral therapy care. However, provision is extremely low with just 8% of infants born to pregnant women with HIV in 2008 initiating cotrimoxazole prophylaxis by two months of age (UNAIDS, 2010). Greater advocacy for the use of cotrimoxazole prophylaxis in children is urgently required. Cotrimoxazole prophylaxis can reduce morbidity and mortality among HIV exposed infants if used consistently. The study focused on determining the factors associated with its compliance by HIV exposed infants in Chikankata District. The findings showed that 78% of mothers/caretakers did not comply with cotrimoxazole due to several factors: socio-cultural, misconceptions, lack of social support, non availability of the drug at health facility, negative attitude of health care providers and lack of nurses follow up of mothers/caretakers, long distances to health facilities, inadequate staffing levels. This underpins the importance of multi-sectoral response in addressing the pandemic. Englisch, Taschenbuch.
5
Symbolbild
Cotrimoxazole Prophylaxis Compliance Among HIV Exposed Infants (2016)
DE PB NW RP
ISBN: 9783659893674 bzw. 3659893676, in Deutsch, LAP Lambert Academic Publishing Jul 2016, Taschenbuch, neu, Nachdruck.
Lieferung aus: Deutschland, Versandkostenfrei.
Von Händler/Antiquariat, AHA-BUCH GmbH [51283250], Einbeck, Germany.
This item is printed on demand - Print on Demand Neuware - 96 pp. Englisch.
Von Händler/Antiquariat, AHA-BUCH GmbH [51283250], Einbeck, Germany.
This item is printed on demand - Print on Demand Neuware - 96 pp. Englisch.
6
Symbolbild
Cotrimoxazole Prophylaxis Compliance Among HIV Exposed Infants (2016)
DE PB NW RP
ISBN: 9783659893674 bzw. 3659893676, in Deutsch, Lap Lambert Academic Publishing, Taschenbuch, neu, Nachdruck.
Lieferung aus: Deutschland, Versandkostenfrei.
Von Händler/Antiquariat, English-Book-Service Mannheim [1048135], Mannheim, Germany.
This item is printed on demand for shipment within 3 working days.
Von Händler/Antiquariat, English-Book-Service Mannheim [1048135], Mannheim, Germany.
This item is printed on demand for shipment within 3 working days.
7
Cotrimoxazole Prophylaxis Compliance Among HIV Exposed Infants
~EN PB NW
ISBN: 3659893676 bzw. 9783659893674, vermutlich in Englisch, LAP Lambert Academic Publishing, Taschenbuch, neu.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…